AngioDynamics Guides FY Sales $631-364M, Had Seen $360-363M vs $359.7M; Guides FY EPS $0.40-0.42, Had Seen $0.49-0.51 vs $0.54 Est

AngioDynamics

, a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today reported financial results for the fiscal 2013 first quarter ended August 31, 2012. Financial results include Navilyst Medical in the fiscal 2013 first quarter.